Human Vaccines Against Infectious Diseases

Around 25% of deaths globally are attributed to infectious diseases, especially in children under the age of five. If the right tools could be put in place to ensure that all children get access to basic antibodies, regardless of their socioeconomic situation or geographic location, a major portion of the burden of incurable diseases could be lessened. Additionally, new safe and effective vaccines need to be developed for a variety of diseases for which neither a practical nor an accessible preventative intervention strategy exists. The general public, the corporate sector, and the humanitarian sectors must work together to ensure that these new or better antibodies are fully developed and made available to the underprivileged populations as soon as is practical.

  •  Hepatitis A

  • Hepatitis B

    Related Conference of Human Vaccines Against Infectious Diseases

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    September 09-10, 2024

    7th International Conference on Vaccines and Immunology

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Human Vaccines Against Infectious Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in